α-Aminothiazole-γ-aminobutanoic amides as potent, small molecule CCR2 receptor antagonists
Authors:
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (2) , 309-314
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- 4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic propertiesBioorganic & Medicinal Chemistry Letters, 2006
- Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) AntagonistsJournal of Medicinal Chemistry, 2006
- CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis ApproachJournal of Medicinal Chemistry, 2003
- Monocyte Chemoattractant Protein-1 (CCL2) in Inflammatory Disease and Adaptive Immunity: Therapeutic Opportunities and ControversiesMicrocirculation, 2003
- Chemokines as novel therapeutic targets in inflammatory diseasesBiochemical Pharmacology, 2002
- Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor AntagonistsBioorganic & Medicinal Chemistry Letters, 2001
- CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compoundBioorganic & Medicinal Chemistry Letters, 2000
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsJournal of Biological Chemistry, 2000
- Opportunities for novel therapeutic agents acting at chemokine receptorsDrug Discovery Today, 1999
- An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse ModelJournal of Experimental Medicine, 1997